NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02670252,BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT,https://clinicaltrials.gov/study/NCT02670252,,COMPLETED,"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) appears to be an efficient tool to cure standard-risk acute lymphocytic leukemia (ALL) in first CR (CR1) but the choice between BU-based or TBI-based conditioning regimens still remains controversial. In this study, the safety and efficacy of BUCY and TBICY myeloablative conditioning regimens in patients undergoing allo-HSCT for ALL in CR1 are evaluated.",NO,Allogeneic Hematopoietic Stem Cell Transplantation|Busulfan|Total Body Irradiation|Acute Lymphocytic Leukemia,DRUG: Busulfan (BU)|DRUG: Cyclophosphamide (CY)|RADIATION: Total Body Irradiation (TBI),"overall survival (OS), 2 year","leukemia relapse rate, 2 year|disease-free survival (DFS), 2 year|transplant-related mortality (TRM), 2 year",,"Nanfang Hospital, Southern Medical University","Guangzhou First People's Hospital|Zhujiang Hospital|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Third Affiliated Hospital, Sun Yat-Sen University|The First Affiliated Hospital of Zhengzhou University|Xiangya Hospital of Central South University|The Seventh Affiliated Hospital of Sun Yat-sen University|The First Affiliated Hospital of Guangzhou Medical University|Guangdong Second Provincial General Hospital|The Affiliated Hospital of Qingdao University|First People's Hospital of Chenzhou|Guangzhou Panyu Central Hospital",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,550,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,BUCY vs TBICY-ALL-2016,2016-01,2020-02,2022-02,2016-02-01,,2022-04-08,"Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China",
